ArticleInternational journal of impotence research2020
Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease.
Peter Tsambarlis et al.PubMed ↗Publisher ↗
No numbers read from the abstract.